Deleted Tweets From Scott Gottlieb, R-D.C.

Today, #FDA published an editorial in @AnnalsofSurgery and press statement regarding breast implants. We’re committed to thoughtful, scientific, public dialogue concerning breast implant safety and effectiveness, including holding an advisory mtg in 2019 https://t.co/x7MVVIXlGv

Check out FDA’s new #antibioticresistance webpage https://t.co/ErssfyX7Zv, which outlines our work to: • Facilitate product development • Support antimicrobial stewardship • Enhance antimicrobial resistance surveillance • Advance regulatory science

RT @BloombergLaw: NEW: To fight superbugs, the FDA is pairing up with other government agencies to spur antibiotic drug development,… https://t.co/U6Eavu4txI

RT @MedResJourno: The FDA is CARB-loading and @_jacquie_lee's got the story.... #SeeWhatIDidThere #AntibioticResistance #FDA… https://t.co/w209Ci1DIo

RT @SGottliebFDA: In the days since we announced our serious concerns with the epidemic of use of e-cigs by young teens, I’ve received a lo… QT @SGottliebFDA: Parents can play an important role in helping kids understand the risks associated with e-cigarette use. The… https://t.co/I0pkGkjkSy)

RT @steveusdin1: .@SGottliebFDA releases FDA's plan to combat antibiotic resistance, calls for funding https://t.co/P3co2Om7nt

We're committed to those harmed by the storms. #FDA already has over 90 USPHS Commissioned Corps officers, including pharmacists, nurses, physicians, veterinarians, and engineers deployed to help #HurricaneFlorence response efforts; including those on Rapid Deployment Force teams https://t.co/KnZSBQhX3D

RT @FDA_Drug_Info: Have you registered for #FDA’s Opioid and Nicotine Use, Dependence, and Recovery public meeting, featuring keynotes… https://t.co/j0NwYGxAOa

FDA released new policies aimed at advancing third party review program for certain low to moderate risk medical devices. It can make review of these products more efficient, allow #FDA to focus agency resources on products posing higher risk to patients https://t.co/Bj5Klydkhw

RT @SecAzar: We share the growing concern about youth e-cig use and commend @US_FDA for taking critical, immediate & historic ac… https://t.co/kKrXeGafUR

RT @RasuShrestha: The @US_FDA as an ENABLER of #innovation? I say YES! ✔"Here's how the FDA is shaping healthcare innovation"… https://t.co/a9lncSNk5F

RT @statnews: If hospitals could buy "subscriptions" to a certain number of antibiotics, would the bigger potential payoff encour… https://t.co/fgaDUazBNk

To date, there’s no evidence that they’ll be shortages of any critical medical product arising from the current storm. #FDA is tracking over 7,000 FDA-regulated facilities, which includes nearly 3,000 medical product firms, in the areas being impacted by Hurricane Florence.

RT @axios: FDA Commissioner Scott Gottlieb will announce the agency's new approach to antimicrobial resistance today, includin… https://t.co/gLSrFCwwxq

THREAD: FDA reached 30 firms that produce critical drugs and will stay in contact throughout the storm and recovery. We can take measures to mitigate shortages arising from hurricane. We’re also monitoring 10 firms that produce critically important biologics and/or devices

We’re also closely monitoring #HurricaneFlorence’s impact on the food and agriculture industry. #FDA recently updated resources on crops harvested from flooded fields for farmers who have food crops  https://t.co/6TJpnyKx5U and animal food producers: https://t.co/xUunzFYMNR

The CDC estimates that in the United States alone at least 2 million people develop serious infections caused by these antimicrobial-resistant bacteria, such as MRSA, each year. And at least 23,000 people die as a direct result. https://t.co/MEw2LDM8uf https://t.co/bkh0HkfvOF

Antimicrobial resistance (AMR) is a growing threat. In today’s #FDA #SUNDAYTWEETORIAL, I’m going to talk about this serous, complex and costly public health problem and the FDA’s strategies for combating AMR. https://t.co/Xs321faneZ https://t.co/EVMosIV9Uq

Antimicrobial resistance is the ability of microbes (bacteria, viruses, fungi) to resist the effects of drugs – that is, the germs are not killed, and their growth is not stopped. Therefore, we can lose our ability to effectively treat these resistant infections. https://t.co/6mBKejULM4

RT @DrMarcSiegel: ⁦@DrMarcSiegel⁩ ⁦@thehill⁩ ⁦@SGottliebFDA⁩ ⁦@FDASpox⁩ #ECG #Rhythm #DataScience #remote health saves lives “watersh… https://t.co/XRfSK1i6Yf

Today, #FDA published an editorial in @AnnalsofSurgery and press statement regarding breast implants. We’re committed to thoughtful, scientific, public dialogue concerning breast implant safety and effectiveness, including holding an advisory mtg in 2019 https://t.co/x7MVVIXlGv

Check out FDA’s new #antibioticresistance webpage https://t.co/ErssfyX7Zv, which outlines our work to: • Facilitate product development • Support antimicrobial stewardship • Enhance antimicrobial resistance surveillance • Advance regulatory science

RT @BloombergLaw: NEW: To fight superbugs, the FDA is pairing up with other government agencies to spur antibiotic drug development,… https://t.co/U6Eavu4txI

RT @MedResJourno: The FDA is CARB-loading and @_jacquie_lee's got the story.... #SeeWhatIDidThere #AntibioticResistance #FDA… https://t.co/w209Ci1DIo

RT @SGottliebFDA: In the days since we announced our serious concerns with the epidemic of use of e-cigs by young teens, I’ve received a lo… QT @SGottliebFDA: Parents can play an important role in helping kids understand the risks associated with e-cigarette use. The… https://t.co/I0pkGkjkSy)

RT @steveusdin1: .@SGottliebFDA releases FDA's plan to combat antibiotic resistance, calls for funding https://t.co/P3co2Om7nt

We're committed to those harmed by the storms. #FDA already has over 90 USPHS Commissioned Corps officers, including pharmacists, nurses, physicians, veterinarians, and engineers deployed to help #HurricaneFlorence response efforts; including those on Rapid Deployment Force teams https://t.co/KnZSBQhX3D

RT @FDA_Drug_Info: Have you registered for #FDA’s Opioid and Nicotine Use, Dependence, and Recovery public meeting, featuring keynotes… https://t.co/j0NwYGxAOa

FDA released new policies aimed at advancing third party review program for certain low to moderate risk medical devices. It can make review of these products more efficient, allow #FDA to focus agency resources on products posing higher risk to patients https://t.co/Bj5Klydkhw

RT @SecAzar: We share the growing concern about youth e-cig use and commend @US_FDA for taking critical, immediate & historic ac… https://t.co/kKrXeGafUR

RT @RasuShrestha: The @US_FDA as an ENABLER of #innovation? I say YES! ✔"Here's how the FDA is shaping healthcare innovation"… https://t.co/a9lncSNk5F

RT @statnews: If hospitals could buy "subscriptions" to a certain number of antibiotics, would the bigger potential payoff encour… https://t.co/fgaDUazBNk

To date, there’s no evidence that they’ll be shortages of any critical medical product arising from the current storm. #FDA is tracking over 7,000 FDA-regulated facilities, which includes nearly 3,000 medical product firms, in the areas being impacted by Hurricane Florence.

RT @axios: FDA Commissioner Scott Gottlieb will announce the agency's new approach to antimicrobial resistance today, includin… https://t.co/gLSrFCwwxq

THREAD: FDA reached 30 firms that produce critical drugs and will stay in contact throughout the storm and recovery. We can take measures to mitigate shortages arising from hurricane. We’re also monitoring 10 firms that produce critically important biologics and/or devices

We’re also closely monitoring #HurricaneFlorence’s impact on the food and agriculture industry. #FDA recently updated resources on crops harvested from flooded fields for farmers who have food crops  https://t.co/6TJpnyKx5U and animal food producers: https://t.co/xUunzFYMNR

The CDC estimates that in the United States alone at least 2 million people develop serious infections caused by these antimicrobial-resistant bacteria, such as MRSA, each year. And at least 23,000 people die as a direct result. https://t.co/MEw2LDM8uf https://t.co/bkh0HkfvOF

Antimicrobial resistance (AMR) is a growing threat. In today’s #FDA #SUNDAYTWEETORIAL, I’m going to talk about this serous, complex and costly public health problem and the FDA’s strategies for combating AMR. https://t.co/Xs321faneZ https://t.co/EVMosIV9Uq

Antimicrobial resistance is the ability of microbes (bacteria, viruses, fungi) to resist the effects of drugs – that is, the germs are not killed, and their growth is not stopped. Therefore, we can lose our ability to effectively treat these resistant infections. https://t.co/6mBKejULM4

RT @DrMarcSiegel: ⁦@DrMarcSiegel⁩ ⁦@thehill⁩ ⁦@SGottliebFDA⁩ ⁦@FDASpox⁩ #ECG #Rhythm #DataScience #remote health saves lives “watersh… https://t.co/XRfSK1i6Yf